Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 11—November 2015
Dispatch

Economic Costs of Measles Outbreak in the Netherlands, 2013–2014

Anita W.M. SuijkerbuijkComments to Author , Tom Woudenberg, Susan J.M. Hahné, Laura Nic Lochlainn, Hester E. de Melker, Wilhelmina L.M. Ruijs, and Anna K. Lugnér
Author affiliations: National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands (A.W.M. Suijkerbuijk, T. Woudenberg, S.J.M. Hahné, L. Nic Lochlainn, H.E. de Melker, W.L.M. Ruijs, A.K. Lugnér); European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden (L. Nic Lochlainn)

Main Article

Table 1

Estimated direct health care costs during measles outbreak, the Netherlands, 2013–2014*

Type of cost Total no. patients Unit cost, $ Average health care utilization Total cost, $
Physician consultation
Uncomplicated measles, no. visits 2,320 37.35 0.2 17,330
Uncomplicated measles, no. phone calls
 2,320
 18.07
 0.1
 4,192
Hospitalizations, no. cases 181 37.35 1.0 6,760
Other complicated measles, no. cases 199 37.35 2.0 14,865
Treatment for pneumonia in general practice, no. cases†
 75
 16.02
 1.0
 1,202
Length of hospitalization, d
General ward 174 600 4.6 480,240
Intensive care unit 7 2,866 13.1 262,812
Rehabilitation
 1
 447
 245
 109,515
Serologic test results, no. cases† .
Positive 139 21.37 1.0 2,970
Negative
854
 21.37
 1.0
 18,250
DNA/RNA amplification, no. cases‡
Positive 765 251.55 1.0 192,436
Negative
577
 251.55
 1.0
 145,144
Total 1,255,718

*Costs are calculated in 2013 US dollars ($). Total number of measles cases = 2,700. Total cost differs from sum of category costs because of rounding.
†IgM.
‡PCR.

Main Article

Page created: November 16, 2015
Page updated: November 16, 2015
Page reviewed: November 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external